OBJECTIVE: To discuss treatment options for @entity957 . METHODS: A total of 108 @entity1 with biopsy-proven @entity957 , treated between 1984 and 2000, were reviewed, including 82 @entity1 and 26 @entity1 , with ages ranging from 19 to 70 years. Treatments consisted of either radiotherapy and surgery reserved as salvage treatment (Salvage Surgery, 83 @entity1 ), or planned surgery with preoperative radiation (Planned Surgery, 25 @entity1 ). Radiotherapy was delivered primarily in a dosage of 60 - 70 Gy for Salvage Surgery @entity1 and 40 - 50 Gy for Planned Surgery @entity1 . Both salvage and planned surgeries were radical, with resection of the lateral oropharyngeal wall, segmental resection of the mandible and neck dissection. The pectoralis major myocutaneous flaps were used to repair surgical defects. RESULTS: The percentages of radical surgery used in the Salvage Surgery and Planned Surgery groups were 24.1% (20/83) and 88.0% (22/25), respectively (P = 0.000). The local recurrence rates were 28.9% (24/83) and 20.0% (5/25) in the Salvage Surgery and Planned Surgery groups, respectively (P = 0.378). The neck recurrence rates were 9.6% (8/83) and 8.0% (2/25) in the Salvage Surgery and Planned Surgery groups respectively (P = 0.804). The 5-year survival rates were 59.3% and 55.3% in the Salvage Surgery and Planned Surgery groups, respectively (P = 0.7056). CONCLUSIONS: Although the two treatments had a similar survival rate, Salvage Surgery avoided 60% commando operations compared with the Planned Surgery group, which benefits to recovery of oral functions. Primary radiotherapy is recommended as the treatment of choice for @entity957 . After radical radiotherapy, salvage surgery should be undertaken in the case of @entity5 remnants or recurrences.

Management of XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'men'] @entity957 :: ('MESH:D002294', 'Disease') :: ['tonsillar squamous cell carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor']
@entity957 :: (MESH:D002294,Disease) :: ['tonsillar squamous cell carcinoma']
